RankingsPricing
  1. JP-listed companies
  2. KISSEI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Revenue

KISSEI PHARMACEUTICAL CO.,LTD.【JP:4547】

Market cap
¥229B
P/E ratio
15.6x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 202588,330+16.87%
Mar 31, 202475,579+11.98%
Mar 31, 202367,493+3.23%
Mar 31, 202265,381-5.31%
Mar 31, 202169,044+9.19%
Mar 31, 202063,234-12.54%
Mar 31, 201972,297-2.31%
Mar 31, 201874,009+3.21%
Mar 31, 201771,706+0.58%
Mar 31, 201671,294+1.69%
Mar 31, 201570,110-0.41%
Mar 31, 201470,399+12.65%
Mar 31, 201362,491-3.29%
Mar 31, 201264,618

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)